Nasdaq Abmd News Today

Robeco Institutional Asset Management B.V. grew its holdings in Abiomed, Inc. (NASDAQ:ABMD – Get Rating) by 20.3% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 14,739 shares of the medical equipment provider’s stock after buying an additional 2,488 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Abiomed were worth […]

Shares of Abiomed, Inc. (NASDAQ:ABMD – Get Rating) reached a new 52-week high during trading on Tuesday . The stock traded as high as $383.59 and last traded at $379.72, with a volume of 51256 shares traded. The stock had previously closed at $252.08. Analysts Set New Price Targets Several research firms have recently commented […]

Victory Capital Management Inc. cut its holdings in shares of Abiomed, Inc. (NASDAQ:ABMD – Get Rating) by 1.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 22,175 shares of the medical equipment provider’s stock after selling 328 shares during the quarter. Victory […]

Bank of Montreal Can reduced its stake in Abiomed, Inc. (NASDAQ:ABMD – Get Rating) by 12.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 48,119 shares of the medical equipment provider’s stock after selling 7,148 shares during the quarter. Bank […]

Abiomed, Inc. (NASDAQ:ABMD – Get Rating) was the target of a large drop in short interest during the month of August. As of August 15th, there was short interest totalling 1,550,000 shares, a drop of 9.4% from the July 31st total of 1,710,000 shares. Currently, 3.5% of the shares of the company are short sold. […]

Zurcher Kantonalbank Zurich Cantonalbank increased its position in Abiomed, Inc. (NASDAQ:ABMD – Get Rating) by 20.1% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,852 shares of the medical equipment provider’s stock after acquiring an additional 1,647 shares during […]

State of Alaska Department of Revenue cut its stake in Abiomed, Inc. (NASDAQ:ABMD – Get Rating) by 10.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 21,367 shares of the medical equipment provider’s stock after selling 2,625 shares during […]

Abiomed, Inc. (NASDAQ:ABMD – Get Rating) has been assigned an average rating of “Hold” from the seven brokerages that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and one has issued a buy recommendation on the company. The average […]

Abiomed (NASDAQ:ABMD – Get Rating) and TELA Bio (NASDAQ:TELA – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations. Risk & Volatility Abiomed has a beta of 1.34, suggesting that […]

Abiomed (NASDAQ:ABMD – Get Rating) will be posting its quarterly earnings results before the market opens on Thursday, April 28th. Analysts expect Abiomed to post earnings of $1.09 per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link. Abiomed (NASDAQ:ABMD – Get Rating) […]